- Conditions
- Niemann-Pick Disease, Type C
- Interventions
- arimoclomol, Placebo
- Drug
- Lead sponsor
- ZevraDenmark
- Industry
- Eligibility
- 2 Years to 18 Years
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2024
- U.S. locations
- 2
- States / cities
- Oakland, California • Rochester, Minnesota
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–6
of 6
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Amyotrophic Lateral Sclerosis
- Interventions
- Arimoclomol, Placebo
- Drug
- Lead sponsor
- ZevraDenmark
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 245 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2020
- U.S. locations
- 10
- States / cities
- Phoenix, Arizona • Orange, California • Miami, Florida + 6 more
- Conditions
- Inclusion Body Myositis
- Interventions
- Arimoclomol
- Drug
- Lead sponsor
- ZevraDenmark
- Industry
- Eligibility
- 45 Years and older
- Enrollment
- 121 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2021
- U.S. locations
- 11
- States / cities
- Phoenix, Arizona • Irvine, California • Aurora, Colorado + 8 more
- Conditions
- Inclusion Body Myositis
- Interventions
- Arimoclomol, Placebo
- Drug · Other
- Lead sponsor
- ZevraDenmark
- Industry
- Eligibility
- 45 Years and older
- Enrollment
- 152 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2021
- U.S. locations
- 11
- States / cities
- Phoenix, Arizona • Irvine, California • Aurora, Colorado + 8 more
- Conditions
- Niemann-Pick Disease, Type C
- Interventions
- Arimoclomol
- Drug
- Lead sponsor
- ZevraDenmark
- Industry
- Eligibility
- 2 Years and older
- U.S. locations
- 13
- States / cities
- Birmingham, Alabama • Oakland, California • Orange, California + 10 more
- Conditions
- Amyotrophic Lateral Sclerosis
- Interventions
- Arimoclomol
- Drug
- Lead sponsor
- ZevraDenmark
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 120 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2021
- U.S. locations
- 7
- States / cities
- Phoenix, Arizona • Orange, California • Miami, Florida + 4 more